Epoetin alfa biosimilar (PT Kalbe)

阿法依伯汀生物类似药 (PT Kalbe)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEpoetin alfa biosimilar (PT Kalbe)
Drug Alias Name促红素α生物仿制药 (PT Kalbe)epoetin alfa follow-on biologic (PT Kalbe)红血球生成素生物仿制药 (PT Kalbe)阿法依泊汀生物仿制药 (PT Kalbe)阿法依伯汀生物仿制药 (PT Kalbe) +[6] 
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionErythropoiesis stimulantsErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsAnemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndonesia
Original Approved Date2003/12/31
Country/TerritoryVietnamSri LankaBurma +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKalbe Farma
China Registration ClassN/A

Develop Information

Active CompaniesKalbe Farma
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeB03XA01
Related LinksN/A